MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • 2025 International Congress

    Inflammatory profile in LRRK2-associated prodromal and clinical PD:a cross-sectional study

    CC. Fan, JY. Liu, JH. Ma, XL. Liu, P. Chan, SY. Liu (Beijing, China)

    Objective: To investigate the peripheral inflammatory cytokine levels and their associations with clinical severity, dopaminergic presynaptic degeneration in asymptomatic carriers and PD patients with LRRK2 mutation.To investigate…
  • 2025 International Congress

    Neuroinflammatory response is determined by HLA genotype in progressive supranuclear palsy

    G. Kovacs, H. Chasiotis, S. Zaheer, J. Wang, J. Li, MC. Tartaglia, S. Fox, A. Lang, S. Forrest (Toronto, Canada)

    Objective: Our aim was to examine whether the HLA haplotypes influence the neuroinflammatory response in a cohort of neuropathologically diagnosed PSP cases. Background: Progressive supranuclear…
  • 2025 International Congress

    Plasma Protein Profiles Reveal Distinct Molecular Signatures in Parkinson’s Disease and Multiple System Atrophy

    SJ. Chung, S. Jo, I. Jang, J. Lee, M. Choi, E. Lee (Seoul, Republic of Korea)

    Objective: We aimed to identify distinct plasma proteins in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA) and evaluate their associations with disease…
  • 2025 International Congress

    Effects of conventional and adaptive deep brain stimulation on systemic oxy-Inflammation in Parkinson’s Disease

    N. Maiorana, S. Marceglia, S. Mrakic-Sposta, A. Vezzoli, M. Guidetti, F. Martinelli Boneschi, T. Bocci, S. Oliveri, P. Signorelli, R. Ferrucci, A. Priori (Milan, Italy)

    Objective: This study investigates the impact of conventional (cDBS) and adaptive deep brain stimulation (aDBS) on systemic oxidative stress (OxS) and inflammation in Parkinson’s Disease…
  • 2025 International Congress

    Spectrum of Movement Disorders Associated With Autoimmune Thyroid Disease

    A. Maheshwary, S. Anderson, N. Prakash (Farmington, USA)

    Objective: To describe the spectrum of movement disorders in patients with positive anti-thyroid antibodies (ATA+). Background: Autoimmune thyroid diseases (AITD), including Hashimoto’s thyroiditis (HT) and…
  • 2025 International Congress

    Distinct Peripheral Immune Profiles of Parkinson’s Disease and Multiple System Atrophy

    S. Jo, I. Jang, J. Lee, M. Choi, E. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to compare peripheral blood mononuclear cell (PBMC) subsets between Parkinson’s disease (PD) and multiple system atrophy (MSA) to identify disease-specific immune signatures…
  • 2025 International Congress

    Chronic Exercise and Systemic Inflammation in Parkinson’s Disease: Exploring the Role of Exercise Modality

    J. Cristini, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)

    Objective: To investigate the effects of 12 weeks of cardiovascular, resistance, multimodal training, or a waiting list condition on the concentrations of inflammatory blood markers…
  • 2024 International Congress

    Characterization of Autoimmune Parkinsonism. A case series

    W. Trillo Alvarez, C. Ibañez Escalante, A. Escalante Mercado, P. Bermejo Rosado, L. Delgado Villanueva, A. Aquino Toledo, R. Huanca Machon (Arequipa, Peru)

    Objective: To report the presentation features in autoimmune parkinsonism in a neurological reference center in Arequipa Peru. Background: Epidemiological studies suggest that a rare association…
  • 2024 International Congress

    Insulin-like growth factor 2 and inflammatory response in Parkinson Disease: Potential predictor marker

    CA. Aguilera, FG. Grünenwald, VU. Urbina, EL. Larraechea, RLV. Vidal (Santiago, Chile)

    Objective: Clinical diagnosis Parkinson's disease (PD), is often difficult, with the appearance of motor symptoms hence the importance of identify non-invasive early markers is a…
  • 2024 International Congress

    Mitigating The Impact Of Covid-19 On Parkinson’s Disease: Insights From Vaccination Strategies

    J. Salimjonov, KH. Khalimova, N. Rashidova, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: This study aimed to investigate the impact of COVID-19 infection on patients with Parkinson's disease (PD), comparing those who received COVID-19 vaccines and those…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley